A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector.
Despite an overall increase in average daily dollar trading volume, some of the industry’s giants are facing liquidity challenges.
Interested in the latest developments in the industry? Stay abreast at the upcoming Benzinga Cannabis Capital Conference in Florida on April 16-17. The two-day event at The Diplomat Beach Resort is a chance for entrepreneurs, both large and small, to network, learn, and grow. Get your tickets now on bzcannabis.com – Prices will increase very soon!
Surge in Trading Volume With Liquidity Caveats
The report points out noticeable increases in trading activity, with all fourteen companies examined showing a higher average dollar volume in 2024 compared to 2023.
The growth in trading volume ranged from 25% for Schwazze (OTC:SHWZ) to a striking 292% for AYR Wellness (OTC:AYRWF).
This surge comes amidst a firmer cannabis equity market and anticipations of a transition to Schedule 3, suggesting an improved market outlook.
However…
However, a deeper dive into the data reveals a concerning trend for major Multi-State Operators (MSOs) such as Curaleaf(OTC:CURLF), GlassHouse (OTC:GLASF), GTI (OTC:GTBIF), Cresco (OTC:CRLBF), Trulieve (OTC:TCNNF) and AYR.
Despite their increased trading volumes, these companies have experienced an increase in
